Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
Eluxadoline is a newly approved orally administered drug used for the treatment of Irritable Bowel Syndrome with Diarrhea. It is reported as a poorly water-soluble drug due to which its dissolution rate and oral bioavailability are very poor. In this work, various plain PLGA nanoparticles (NPs) (F1-...
Saved in:
Main Authors: | Md. K. Anwer (Author), Ramadan Al-Shdefat (Author), Essam Ezzeldin (Author), Saad M. Alshahrani (Author), Abdullah S. Alshetaili (Author), Muzaffar Iqbal (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box-Behnken Design, and Anti-Diarrheal Activity
by: Md. Khalid Anwer, et al.
Published: (2023) -
Development of Lipomer Nanoparticles for the Enhancement of <i>Drug</i> Release, Anti-Microbial Activity and Bioavailability of Delafloxacin
by: Md. Khalid Anwer, et al.
Published: (2020) -
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Özdener AE, et al.
Published: (2017) -
Improving the Solubilization and Bioavailability of Arbidol Hydrochloride by the Preparation of Binary and Ternary β-Cyclodextrin Complexes with Poloxamer 188
by: Md. Khalid Anwer, et al.
Published: (2021) -
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Sobolewska-Włodarczyk A, et al.
Published: (2016)